ArticleRisk management and healthcare policy2026
Risk Factors of Thyroid Dysfunction in Patients with Acute Pancreatitis and Predictive Value of TSH for Disease Severity.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with acute pancreatitis (AP) commonly present with thyroid dysfunction in clinic. The present study aimed to characterize thyroid dysfunction in AP patients, identify the risk factors, assess its dynamics during AP resolution and evaluate its value for predicting AP severity. Methods: A total of 182 AP patients and 61 age- and gender-matched patients with chronic pancreatitis (CP) were enrolled. Demographic characteristics, biochemical parameters and thyroid function were collected. Results: AP patients had an average age of 53.3±16.7 years and 61.5% were males; CP patients had an average age of 52.7±11.9 years and 59.0% were males. Compared with CP group, the level of T3, T4, FT3 and TSH was significantly lower in AP group. A high prevalence of thyroid dysfunction (87.4%), manifested as decreased thyroid hormones and TSH, was observed in AP patients. The extent of hormone reduction was progressively exacerbated with increasing the disease severity. Albumin (Alb) was independently positive correlation, and hs-CRP and lactate (Lac) were independently negatively correlated with thyroid function. The levels of thyroid hormones and TSH increased during AP resolution. TSH demonstrated superior predictive value for moderate-to-severe AP compared to traditional markers (hs-CRP, Alb, Ca) and established severity scores (APACHE II, BISAP). The cut-off value of TSH was 0.42 µIU/mL with the highest AUC (0.772 (0.693-0.851)) and the highest Youden's index (0.478). Conclusion: Thyroid dysfunction was common in AP patients, characterized by a reduction in thyroid hormones and TSH. Lower Alb and higher hs-CRP and Lac were independent risk factors of thyroid dysfunction. During AP resolution, thyroid dysfunction could spontaneously recover. Furthermore, a low level of TSH at admission showed promising predictive value for moderate to severe AP in the early stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.